No Chance to Survive: Mo-CBP3-PepII Synthetic Peptide Acts on Cryptococcus neoformans by Multiple Mechanisms of

Tawanny K B Aguiar1, Felipe P Mesquita2, Nilton A S Neto1

  • 1Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza 60451-970, CE, Brazil.

Insights

The synthetic peptide Mo-CBP3-PepII effectively kills Cryptococcus neoformans by inducing oxidative stress and disrupting cellular functions. This multi-pronged attack on fungal cells suggests potential for new drug development against resistant infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Multidrug-resistant *Cryptococcus neoformans* poses a significant threat to immunocompromised individuals, leading to high mortality rates.
  • The synthetic peptide *Mo*-CBP3-PepII has shown potent anticryptococcal activity at low concentrations.

Purpose of the Study:

  • To elucidate the detailed mechanisms of action of *Mo*-CBP3-PepII against *Cryptococcus neoformans*.
  • To provide insights into how *Mo*-CBP3-PepII induces cell death in *C. neoformans*.

Main Methods:

  • Light and fluorescence microscopy were used to observe cellular changes.
  • Enzymatic activity assays assessed key enzymes like SOD, APX, CAT, and LDH.
  • Proteomic analysis identified alterations in protein abundance.
  • Experiments included treatment with ascorbic acid to investigate the role of reactive oxygen species.

Main Results:

  • *Mo*-CBP3-PepII induced accumulation of superoxide anion and hydrogen peroxide, while reducing SOD, APX, and CAT activity.
  • The peptide's anticryptococcal activity was abolished by ascorbic acid, indicating the crucial role of reactive oxygen species (ROS).
  • Inhibition of lactate dehydrogenase (LDH) and ergosterol biosynthesis, along with cytochrome c decoupling from mitochondrial membranes, were observed.
  • Proteomic analysis revealed decreased protein levels involved in energy metabolism, DNA/RNA metabolism, pathogenicity, protein metabolism, cytoskeleton, and cell wall organization.

Conclusions:

  • *Mo*-CBP3-PepII exhibits multiple mechanisms of action against *C. neoformans*, including ROS generation and disruption of essential cellular processes.
  • The multifaceted attack by *Mo*-CBP3-PepII may hinder the development of resistance in *C. neoformans*.
  • This peptide represents a promising candidate for the development of novel therapeutic agents against *Cryptococcus neoformans* infections.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...